Megan L Allen, Adam Pastor, Kate Leslie, Brennan Fitzpatrick, Malcolm Hogg, Hui Lau, Jo-Anne Manski-Nankervis
{"title":"Patient experience of discharge opioid analgesia and care provision following spine surgery: A mixed methods study.","authors":"Megan L Allen, Adam Pastor, Kate Leslie, Brennan Fitzpatrick, Malcolm Hogg, Hui Lau, Jo-Anne Manski-Nankervis","doi":"10.1177/20494637251322168","DOIUrl":"10.1177/20494637251322168","url":null,"abstract":"<p><strong>Background: </strong>Perioperative opioid stewardship programs are increasingly being introduced to guide responsible use around the time of surgery to reduce opioid-related harm to patients. However, patient experiences of perioperative opioid stewardship programs are underexplored.</p><p><strong>Methods: </strong>We designed a mixed methods study to explore patients' experiences of perioperative opioid stewardship in the post-operative period following spine surgery. We performed evaluative action research, combining quality improvement and ethnographic methodologies. Our quantitative methods were retrospective medical record review and targeted survey research. Our qualitative methods were online focus groups. The quantitative data were analysed using descriptive statistics, chi-square, and rank sum testing. The focus group data underwent inductive thematic analysis.</p><p><strong>Results: </strong>Our spine surgery cohort for the four-month study period included 101 patients. The median total discharge opioid dispensed was 75 mg [interquartile range 75-150 mg], with 30% of patients prescribed modified release opioids on discharge. A subset of patients (<i>N</i> = 14) participated in the online focus groups. The key themes that emerged from these sessions were (1) Supportive care delivery and rescue mechanisms were universally important to patient participants, providing great reassurance during their recovery; (2) Participants commonly believed opioid analgesia had an important role in recovery following spine surgery. Some patients were keen to dispose of surplus opioids whilst others intended to retain them; (3) Opioid analgesia access was variable, but established community prescriber relationships were important for post-discharge opioid re-prescription, and (4) The key future improvement suggestions included routine post-discharge contact and enhanced communication options back to the hospital if needed.</p><p><strong>Discussion and conclusions: </strong>Our mixed methods approach provided rich insights into the pain and opioid analgesia experiences of patients following spine surgery. These insights are useful when seeking to optimise perioperative opioid stewardship programs including better meeting the needs of patient consumers. Limitations included potential response and selection bias for the online focus groups towards younger, higher socioeconomic status patients.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637251322168"},"PeriodicalIF":1.3,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11840826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicolas G Glynos, Anne Baker, Jacob S Aday, Daniel Kruger, Kevin F Boehnke, Stephanie Lake, Philippe Lucas
{"title":"Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.","authors":"Nicolas G Glynos, Anne Baker, Jacob S Aday, Daniel Kruger, Kevin F Boehnke, Stephanie Lake, Philippe Lucas","doi":"10.1177/20494637251319497","DOIUrl":"10.1177/20494637251319497","url":null,"abstract":"<p><p>Psychedelic substances have shown preliminary efficacy for several neuropsychiatric disorders and are currently being investigated for chronic pain conditions. However, few studies have investigated outcomes of naturalistic psychedelic use among individuals with chronic pain, and none have assessed psychedelic-related changes in substance use patterns in this population. In a cross-sectional survey of adults who reported using psychedelics to self-treat a chronic pain condition (<i>n</i> = 466; 46.1% women), we investigated changed substance use patterns and self-reported outcomes on physical and mental health following use of a psychedelic. Most (86.3%; <i>n</i> = 391/453) indicated that they ceased or decreased use of one or more non-psychedelic substances \"as a result of\" psychedelic use, and 21.2% (<i>n</i> = 83/391) indicated that the decrease in use persisted for more than 26 weeks after psychedelic use. Alcohol (71.1%; <i>n</i> = 226/318) and prescription opioids (64.1%; <i>n</i> = 100/156) had the highest proportions for ceased/decreased use. Illicit opioids (27.8%; <i>n</i> = 22/79) and cannabis (21.5%; <i>n</i> = 78/362) had the highest proportions for increased/initiated use. In multivariate regression modeling, having a motivation to reduce one's substance use was positively associated with ceasing/decreasing substance use (<i>p</i> < .001). Perceptions of health outcomes following psychedelic use were broadly positive, and psilocybin was reported to be the most effective substance for both physical and mental health symptoms. Although limited by a cross-sectional study design, findings from this large sample merit future investigation into the benefits and risks of naturalistic psychedelic use among individuals with chronic pain.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637251319497"},"PeriodicalIF":1.3,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11811946/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143410728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
British Journal of PainPub Date : 2025-02-01Epub Date: 2025-02-06DOI: 10.1177/20494637251313896
Jan Vollert, Nadia Soliman
{"title":"Chronic pain as a long-term burden for veterans.","authors":"Jan Vollert, Nadia Soliman","doi":"10.1177/20494637251313896","DOIUrl":"10.1177/20494637251313896","url":null,"abstract":"","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":"19 1","pages":"4-5"},"PeriodicalIF":1.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11803606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gerlinde Pilkington, Mark I Johnson, Kate Thompson
{"title":"Social prescribing for adults with chronic pain in the U.K.: a rapid review.","authors":"Gerlinde Pilkington, Mark I Johnson, Kate Thompson","doi":"10.1177/20494637241312064","DOIUrl":"10.1177/20494637241312064","url":null,"abstract":"<p><strong>Introduction: </strong>Social prescribing links patients to community groups and services to meet health needs; however, it is uncertain what the benefits and impacts of social prescribing are for people with chronic pain. The National Institute for Health and Care Excellence (NICE) undertook a systematic review to investigate the clinical and cost effectiveness of social interventions aimed at improving the quality of life of people with chronic pain; no relevant clinical studies comparing social interventions with standard care for chronic pain were found, though the inclusion criteria for studies was narrow.</p><p><strong>Objectives: </strong>To undertake a rapid review of all types of research and policy on social prescribing for adults with chronic pain in the U.K. (i) to describe the characteristics of relevant research and (ii) to synthesise data on impact.</p><p><strong>Methods: </strong>A two-stage rapid review was planned. Stage (i) scoped and categorised knowledge from a comprehensive representation of the literature. In stage (ii), we undertook a descriptive synthesis of quantitative data along with a thematic analysis of qualitative data identified by stage (i).</p><p><strong>Results: </strong>Of 40 full-text records assessed for inclusion, three met the inclusion criteria from academic databases. An additional five records were found in grey literature. Six records reported quantitative findings suggesting that social prescribing reduced pain severity and discomfort, pain medication and clinical appointments; and improved quality of life and ability to manage health. Five records captured qualitative data from interviews, case studies and anecdotal quotes that suggested positive impact on health and wellbeing; and increased self-efficacy in social prescribers undertaking training on pain.</p><p><strong>Conclusions: </strong>There is tentative evidence that social prescribing improves health and wellbeing outcomes in adults with chronic pain and that there is a need to upskill social prescribers in contemporary pain science education. Research on the routes to referral, outcomes and impacts is needed.</p><p><strong>Perspective: </strong>Social prescribing is valued and may be of benefit for people with chronic pain. There is a need to further develop and evaluate social prescribing services for people with chronic pain to enhance holistic patient centered care.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241312064"},"PeriodicalIF":1.3,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11752153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jenna L Gillett, Arman Rakhimov, Paige Karadag, Kristy Themelis, Chen Ji, Nicole Ky Tang
{"title":"Self-compassion in chronic pain: Validating the self-compassion scale short-form and exploring initial relationships with pain outcomes.","authors":"Jenna L Gillett, Arman Rakhimov, Paige Karadag, Kristy Themelis, Chen Ji, Nicole Ky Tang","doi":"10.1177/20494637241312070","DOIUrl":"10.1177/20494637241312070","url":null,"abstract":"<p><strong>Objectives: </strong>Validate the English version of the <i>Self-C</i> <i>ompassion</i> <i>Scale S</i> <i>hort-F</i> <i>orm</i> (SCS-SF) as a reliable measure in chronic pain. Explore self-compassion's relationship with pain-related outcomes.</p><p><strong>Methods: </strong>A total of 240 chronic pain patients (at 6-months) and 256 community participants (at 12-months) completed two prospective survey studies. SCS-SF psychometric properties were evaluated through exploratory and confirmatory factor analyses (EFA and CFA), exploratory structural equation modelling (ESEM), test-retest reliability (Pearson's r) and internal consistency (Cronbach's α) in both samples. Convergent validity/clinical relevance was assessed in the chronic pain sample via univariate linear regressions between self-compassion and pain intensity, interference, catastrophizing, self-efficacy, anxiety and depression.</p><p><strong>Results: </strong>The SCS-SF showed acceptable internal consistency in both samples (α > 0.70, range = 0.74-0.79), high test-retest reliability over 6-months in the pain sample (r = 0.81, <i>p</i> < .001) and sub-threshold over 12-months in the community (r = 0.59 <i>p</i> < .001). EFA revealed a two-factor model distinguishing compassionate and uncompassionate self-responding in both samples. CFA identified a one-factor and two-factor model in both samples, but it did not meet statistical thresholds. ESEM identified the best fit for the chronic pain group was for a two-factor model (RMSEA and SRMR < 0.08; CFI and TLI > 0.90), whereas no models met acceptable fit criteria in the community group. A two-bifactor Bayesian model had suitable fit in both groups. In the chronic pain sample, SCS-SF and compassionate self-responding negatively predicted pain intensity, interference, anxiety, depression, catastrophizing and positively predicted self-efficacy over 6-months. Uncompassionate self-responding positively predicted anxiety, depression, catastrophizing and negatively predicted self-efficacy but did not predict pain outcomes.</p><p><strong>Discussion: </strong>The SCS-SF is a reliable and valid measure in chronic pain. Total and sub-factor scores appear to have distinct relationships with pain outcomes. Future research should consider self-compassion as a unitary and/or bifactorial (consisting of compassionate and uncompassionate self-responding) construct in chronic pain when measured using the SCS-SF.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241312070"},"PeriodicalIF":1.3,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lydia V Tidmarsh, Richard Harrison, Harriet Wilkinson, Megan Harrington, Katherine A Finlay
{"title":"Activating waitlists: Identifying barriers and facilitators to pain self-management while waiting.","authors":"Lydia V Tidmarsh, Richard Harrison, Harriet Wilkinson, Megan Harrington, Katherine A Finlay","doi":"10.1177/20494637241311456","DOIUrl":"https://doi.org/10.1177/20494637241311456","url":null,"abstract":"<p><strong>Objectives: </strong>Waitlists for pain management services are often extensive, risking psychological and physical decline and patient non-engagement in treatment once accessed. Currently, for outpatient pain management, no standardised waiting list interventions exist, resulting in passive waiting. To arrest prospective wait-related decline(s), this study aimed to identify the barriers and facilitators to pain self-management while waiting, forming the foundation for a waitlist intervention development.</p><p><strong>Design: </strong>An inductive qualitative approach was utilised to explore the barriers and drivers of pain self-management while waiting for chronic pain management.</p><p><strong>Method: </strong>Semi-structured interviews, underpinned by the Theoretical Domains Framework and COM-B model, were conducted with people waiting for pain management services (<i>N</i> = 38). Interviews were audio-recorded, transcribed verbatim, and analysed via reflexive thematic analysis.</p><p><strong>Results: </strong>The analysis demonstrated four thematised barriers and one facilitator: (1) Shunted Around the System <i>(barrier)</i>; (2) The Information Gap <i>(barrier)</i>; (3) Resisting Adaptation (<i>barrier</i>); (4) Losing Hope (<i>barrier);</i> and (5) Help Yourself or Lose Yourself <i>(facilitator)</i>.</p><p><strong>Conclusion: </strong>This study demonstrates the severe emotional and motivational impact of waiting, increasing treatment disengagement. The waitlist represents a prime opportunity for prehabilitation to protect wellbeing and optimise self-management engagement. Infrastructural and interpersonal barriers of poor communication and healthcare professional pain invalidation must be addressed to improve emotional wellbeing and motivation to engage with planned treatment. Enhancing self-efficacy, pain acceptance, self-compassion, and internal HLOC are fundamental to increasing pain self-management. These can all be met within a prehabilitation framework. This study is foundational for the development of psychological prehabilitation in outpatient chronic pain management.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241311456"},"PeriodicalIF":1.3,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Allan Botura Brennecke, Eduardo Silva Reis Barreto, Liliane Lins-Kusterer, Liana Maria Torres de Araujo Azi, Durval Kraychete
{"title":"Impact of different treatments for chronic pain on cognitive function: A systematic review.","authors":"Allan Botura Brennecke, Eduardo Silva Reis Barreto, Liliane Lins-Kusterer, Liana Maria Torres de Araujo Azi, Durval Kraychete","doi":"10.1177/20494637241311784","DOIUrl":"https://doi.org/10.1177/20494637241311784","url":null,"abstract":"<p><strong>Introduction: </strong>Experimental evidence supports the hypothesis of reciprocal influence between neural systems involved in cognition and central pain processing circuits. Furthermore, studies have demonstrated bidirectional communication between central pain processing areas and the immune system, leading to changes in behaviour, sensory perception, mood, and cognition. However, the academic community has not yet reached a consensus on whether effective analgesic interventions can mitigate or reverse cognitive deterioration.</p><p><strong>Methods: </strong>This systematic review evaluated the effectiveness of various therapeutic interventions in improving cognitive functions (primary outcome) and altering the profile of immunological markers (secondary outcome) in chronic pain patients. The review was limited to randomised controlled trials addressing chronic pain of any aetiology, with searches conducted in PubMed, EMBASE, and Scopus databases.</p><p><strong>Results: </strong>The qualitative synthesis of twelve studies conducted between 2003 and 2021, involving 1432 participants in experimental (<i>n</i> = 950) and control (<i>n</i> = 482) groups, revealed some interesting patterns. Only half of the studies (6/12) reported cognitive improvement, with attention being the most analysed cognitive domain, followed by memory and executive function. Fibromyalgia was the most studied aetiology of chronic pain. The strategies of intervention/treatment and durations varied widely; however, milnacipran versus placebo emerged as the most frequently employed intervention. Only one study reported immunological markers, limiting the evaluation of this outcome.</p><p><strong>Conclusion: </strong>Based on this analysis, it is not possible to affirm that interventions targeting chronic pain improve cognition. This review suggests new research directions and calls for more robust methodological approaches.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241311784"},"PeriodicalIF":1.3,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701906/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case series of new-onset headache and neurological issues after thoracolumbar spinal cord stimulators.","authors":"Ramkumar Kalaiyarasan, Hemkumar Pushparaj, Manohar Sharma","doi":"10.1177/20494637241310705","DOIUrl":"https://doi.org/10.1177/20494637241310705","url":null,"abstract":"<p><p>Although spinal cord stimulator (SCS) therapy is generally used safely to treat chronic neuropathic pain conditions, this document highlights the less reported complication of unusual neurological problems including headaches. These developed temporally after the initiation of SCS therapy despite initial positive response to pain. The mechanisms might include activation of trigeminal receptors and neuroplasticity after SCS. We present a series of four cases where patients developed new neurological symptoms like headaches, facial twitching, and tinnitus, that were related to SCS activation. Despite adjustments to the SCS settings and extensive evaluations, these symptoms persisted in all cases, leading to the decision to explant SCS which was otherwise helping pain.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241310705"},"PeriodicalIF":1.3,"publicationDate":"2025-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Global and regional trends and projections of chronic pain from 1990 to 2035: Analyses based on global burden of diseases study 2019.","authors":"Mengyi Zhu, Jiarui Zhang, Diefei Liang, Junxiong Qiu, Yuan Fu, Zhaopei Zeng, Jingjun Han, Junmeng Zheng, Liling Lin","doi":"10.1177/20494637241310697","DOIUrl":"10.1177/20494637241310697","url":null,"abstract":"<p><strong>Background: </strong>Chronic pain poses a significant public health challenge. We present the global and regional data on Prevalence, Incidence and Years Lived with Disability (YLDs) for Chronic pain from the Global burden of disease (GBD) study 2019 data and analyze their associations with Socio-demographic index (SDI), age, and gender, and the future trends from 2020 to 2035.</p><p><strong>Methods: </strong>Regional trends in the burden of chronic pain and its association with age, gender, and SDI were assessed from 1990 to 2019. Joinpoint analysis was employed to describe trends in chronic pain burden across different SDI regions. Additionally, the Bayesian Age-Period-Cohort model (BAPC) was used for predicting future trends. Age-standardized rates (ASRs) of prevalence, incidence, and YLDs were employed to quantify the burden of chronic pain.</p><p><strong>Results: </strong>Between 1990 and 2019, a significant increase was observed in global prevalence and YLDs rates of chronic pain. Higher rates were found among females, whereas a faster rise was noted among males. Notably, Low Back Pain (LBP) and Migraine accounted for predominant YLDs globally, particularly among those aged 75 and above. A notable prevalence of Tension-type Headache (TTH) was observed among younger populations. Furthermore, ASRs for chronic pain were highest in high-SDI regions. Projections suggest an increase in headache ASRs globally for both genders from 2020 to 2035.</p><p><strong>Conclusion: </strong>From 1990 to 2019, the global burden of chronic pain increased significantly, with projections indicating a continued rise in headache burden over the next 15 years, underscoring the need for heightened attention to these issues.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241310697"},"PeriodicalIF":1.3,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11669129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gwyneth Doherty-Sneddon, Roberta Caiazza, Emilia Pawlowska, Quoc Vuong
{"title":"Impact of equine interactions on human acute pain perception: Two cross sectional studies.","authors":"Gwyneth Doherty-Sneddon, Roberta Caiazza, Emilia Pawlowska, Quoc Vuong","doi":"10.1177/20494637241302391","DOIUrl":"https://doi.org/10.1177/20494637241302391","url":null,"abstract":"<p><strong>Background: </strong>Research has demonstrated the effectiveness of Animal-Assisted Therapy, usually involving dogs, as a way to reduce pain in inpatient and outpatient populations. Here two studies investigate the effectiveness of interacting with horses for reducing human acute pain perception.</p><p><strong>Methods: </strong>In Study 1, a blood-pressure cuff was used to administer acute ischaemic pain to 70 adult participants, who were allocated to one of three groups: Equine Assisted Psychotherapy (EAP), Horse Interaction without EAP (HI), and a Control (no horses present). All participants engaged in an activity (finding a horse treat) in a large, enclosed arena. The dependent variable was the subjective pain rating (scale 0-10) of the participant in response to moderate pain induced pre- and post-activity. In Study 2, 53 adult participants were recruited and allocated to either an Equine Assisted Learning (EAL) Group or a Control Group. The same paradigm was used. Following the activity sessions, qualitative data was elicited from the participants regarding their insights and feelings. It was hypothesized that any interaction with horses would significantly reduce an individual's perception of pain.</p><p><strong>Results: </strong>In both studies, planned paired-samples t-tests showed significant reductions in pain ratings from pre-activity to post-activity in the EAL, EAP and HI groups (large and medium effect sizes) but not the Control groups. Thematic analysis of the qualitative responses showed an overwhelmingly positive array of responses from those who interacted with the horses, for example, feeling relaxed and happy during the activity.</p><p><strong>Conclusion: </strong>Interactions with horses can reduce acute pain perception. Distraction, physiological changes, and positive emotions are discussed as possible underlying mechanisms. It remains to be seen how this could be more widely applied, for example, in relation to chronic pain.</p>","PeriodicalId":46585,"journal":{"name":"British Journal of Pain","volume":" ","pages":"20494637241302391"},"PeriodicalIF":1.3,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11607707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142773631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}